| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 09/08/2000 | WO2000051642A1 Combination therapy of angiotensin converting enzyme inhibitor and epoxy-steroidal aldosterone antagonist for treatment of cardiovascular disease |
| 09/08/2000 | WO2000051614A1 Inhibitors of prenyl-protein transferases |
| 09/08/2000 | WO2000051612A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | WO2000051611A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | WO2000051604A1 Intermittent claudication remedies |
| 09/08/2000 | WO2000051595A1 Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using r(-)-ketoprofen |
| 09/08/2000 | WO2000051547A2 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | WO2000051444A1 Utilization of material containing docosapentaenoic acid |
| 09/08/2000 | WO2000029583A3 Immunoglobulin superfamily proteins |
| 09/08/2000 | WO2000027418A3 A method for treating tissue damaged from ischemia |
| 09/08/2000 | WO2000027414A3 Inhibition of the formation of vascular hyperpermeability |
| 09/08/2000 | WO2000019883A3 Compositions and methods of disease diagnosis and therapy |
| 09/08/2000 | WO2000013702A3 Use of an angiogenic factor for the treatment of microvascular angiopathies |
| 09/08/2000 | WO2000012720A3 Elongase genes and uses thereof |
| 09/08/2000 | WO2000012497B1 Quinazoline derivatives as medicaments |
| 09/08/2000 | WO2000007579A3 Use of cyclopentabenzofuran-derivatives for combating nf-$g(k)b-dependent diseases |
| 09/08/2000 | WO1999034784A3 Pharmaceutical compositions comprising disulfiram for inhibiting angiogenesis |
| 09/08/2000 | CA2373463A1 Intermittent claudication remedies |
| 09/08/2000 | CA2371846A1 Methods and reagents for inhibiting proliferation of smooth muscle cells |
| 09/08/2000 | CA2364415A1 Embryonic or stem-like cell lines produced by cross species nuclear transplantation |
| 09/08/2000 | CA2364169A1 Combination therapy of angiotensin converting enzyme inhibitor and epoxy-steroidal aldosterone antagonist for treatment of cardiovascular disease |
| 09/08/2000 | CA2363488A1 Heart abnormalities in vascular endothelial growth factor b (vegf-b) deficient animals and methods relating to these heart abnormalities |
| 09/08/2000 | CA2363139A1 Methods and reagents for inhibiting angiogenesis |
| 09/08/2000 | CA2362778A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2362495A1 Inhibitors of prenyl-protein transferases |
| 09/08/2000 | CA2362494A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2362493A1 Inhibitors of prenyl-protein transferase |
| 09/08/2000 | CA2362489A1 Methods and compositions for the treatment of neuropathic pain, tinnitus, and other disorders using r(-)-ketoprofen |
| 09/08/2000 | CA2360740A1 Compounds useful as reversible inhibitors of cathepsin s |
| 09/08/2000 | CA2330541A1 Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| 09/06/2000 | EP1033366A2 Amide derivatives useful as Neuropeptide Y (NPY) antagonists |
| 09/06/2000 | EP1033364A1 Cyano containing oxamic acids and derivatives as thyroid receptor ligands |
| 09/06/2000 | EP1033134A1 Compositions inhibiting smooth muscle proliferation, method for the diagnosis of arteriosclerosis, and kits therefor |
| 09/06/2000 | EP1032682A1 Desaturase genes and their use |
| 09/06/2000 | EP1032656A1 Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor |
| 09/06/2000 | EP1032575A1 2,3-diaryl-pyrazolo(1,5-b)pyridazines derivatives, their preparation and their use as cyclooxygenase 2 (cox-2) inhibitors |
| 09/06/2000 | EP1032571A1 Piperidinylaminomethyl trifluoromethyl cyclic ether compounds as substance p antagonists |
| 09/06/2000 | EP1032570A1 Isoquinoline derivatives and their therapeutical use |
| 09/06/2000 | EP1032560A1 Position-4 substituted 2-pyrrolidinone derivatives to reduce the level of extracellular glutamate |
| 09/06/2000 | EP1032556A1 Pharmaceutically active compounds and methods of use |
| 09/06/2000 | EP1032424A1 Combination of an aldose reductase inhibitor and a glycogen phosphorylase inhibitor |
| 09/06/2000 | EP1032423A1 Dna encoding mammalian neuropeptide ff (npff) receptors and uses thereof |
| 09/06/2000 | EP1032414A1 Combination of hypertensin converting enzyme inhibitor with a diuretic for treating microcirculation disorders |
| 09/06/2000 | EP1032403A1 Nutritional supplement for cerebral metabolic insufficiencies |
| 09/06/2000 | EP1032394A1 Use of substituted 11-phenyl-dibenzazepine compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cell proliferation, diarrhea and scour |
| 09/06/2000 | EP1032393A1 QUINOLINE-CONTAINING $g(a)-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
| 09/06/2000 | EP1032385A1 Use of substituted diphenyl indanone, indane and indole compounds for the treatment or prevention of sickle cell disease, inflammatory diseases characterized by abnormal cellproliferation, diarrhe and scours |
| 09/06/2000 | EP1032377A1 Substituted 2-aminoacetamides and the use thereof |
| 09/06/2000 | EP0901379B1 Type-2 chemokine binding proteins and methods of use therefor |
| 09/06/2000 | EP0719145B1 Nitric oxide donor composition for treatment of anal disorders |
| 09/06/2000 | EP0711134B1 Medicinal for protection from neurological damage |
| 09/06/2000 | CN1265674A 4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265672A Sulfonylated dipeptide compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265670A Dipeptide and related compounds which inhibit leukocyte adhesion medicated by VLA-4 |
| 09/06/2000 | CN1265669A Compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265668A Subtsituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265660A 2-(4-aryl or heteroaryl-piperazin-1-ylmethyl)-1H-indole derivatives |
| 09/06/2000 | CN1265658A 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application |
| 09/06/2000 | CN1265657A Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 09/06/2000 | CN1265652A 2-acrylaminopropanamines as tachykinin receptor antagonists |
| 09/06/2000 | CN1265649A Indole derivatives as MCP-1 receptor antagonists |
| 09/06/2000 | CN1265647A Acrylic metalloprotease inhibitor |
| 09/06/2000 | CN1265643A Anthranilic acid analogs |
| 09/06/2000 | CN1265600A Cloning pigs using donor nuclei from differentiated cells |
| 09/06/2000 | CN1265598A Method for treating thrombotic disorders |
| 09/06/2000 | CN1265592A A pharmaceutical composition active in reducing production of MCP-1 protein |
| 09/06/2000 | CN1265591A Coumpound |
| 09/06/2000 | CN1265585A (Imidazol-5-yl) methyl-2-quinolinone derivatives as inhibitors of smooth muscle cell proliferation |
| 09/06/2000 | CN1265308A Application of magnesium fructose-1,6-diphosphate in medicine |
| 09/06/2000 | CN1056180C Drink and manufacture thereof |
| 09/06/2000 | CN1056144C New use of 6-heterocyclic-4-amino-3,4,5-tetrahydrobenz (CD) indoles compound |
| 09/06/2000 | CN1056143C Piperidine derivatives and its use |
| 09/06/2000 | CN1056141C 哌嗪衍生物 Piperazine derivatives |
| 09/06/2000 | CN1056140C Biphenyl derivatives, their preparation and theirt use for treatment of hypertension and cardiac disease |
| 09/06/2000 | CN1056057C Pharmaceutical compositions permitting the prolonged release of trimetazidine after oral administraion |
| 09/06/2000 | CN1056049C Preparing process mangetotherapeutic food |
| 09/05/2000 | US6114568 Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors |
| 09/05/2000 | US6114545 Inhibitors of cholesterol esterase |
| 09/05/2000 | US6114506 Composition and method for enhancing fibrinolysis |
| 09/05/2000 | US6114395 Method of treating atherosclerosis |
| 09/05/2000 | US6114372 Matrix metalloproteinase (mmp); tumor necrosis factor(tnf); compounds such as n2-((2s)-acetylmercapto)acetyl-5-phthalimidopentanoyl)-n1-((4 -methoxybenzene)sulphonyl)-n1-(phenylmethyl)hydrazine |
| 09/05/2000 | US6114365 Arylmethyl-carbonylamino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 09/05/2000 | US6114361 5-oxo-pyrrolidine-2-carboxylic acid hydroxamide derivatives |
| 09/05/2000 | US6114359 Endothelin receptor antagonists |
| 09/05/2000 | US6114341 Treatment of atherosclerosis |
| 09/05/2000 | US6114338 Heterocyclic compounds |
| 09/05/2000 | US6114335 Benzoylguanidine derivatives, process for their preparation their use in the preparation of medicines |
| 09/05/2000 | US6114334 Piperazine derivatives as therapeutic agents |
| 09/05/2000 | US6114329 5-HT4 receptor antagonists useful in the treatment of gastroinstestinal, cardiovascular and CNS disorders |
| 09/05/2000 | US6114328 Isoxazoline and isoxazole fibrogen receptor antagonists |
| 09/05/2000 | US6114322 Anticholesterol agent |
| 09/05/2000 | US6114320 Therapeutic treatment for VEGF related ocular diseases |
| 09/05/2000 | US6114317 Method of locking 1α-OH of vitamin D compounds in axial orientation |
| 09/05/2000 | US6114316 Combination of bisphosphonate and tetracycline |
| 09/05/2000 | US6114311 Administering an adenviral compound |
| 09/05/2000 | US6114303 Therapy for hypotension |
| 09/05/2000 | US6113906 Water-soluble non-antigenic polymer linkable to biologically active material |
| 09/05/2000 | US6113629 Hydrogel for the therapeutic treatment of aneurysms |
| 09/05/2000 | US6113527 3,3-bis-hydroxymethyl-7-(cis-4-isopropyl-cyclohexyl)-1-phenyl -1,7-diaza-spiro-(3.5)nonane-2-one, for example; agonists of the orphanin fq (ofq) receptor; useful in the treatment of psychiatric, neurological and physiological disorders |
| 09/05/2000 | CA2001160C Pyridine derivatives |